300841 康华生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资6,2800.00%6,2806,3536,5000
投资性房地产0--0000
固定资产807,797-8.20%880,000955,906849,035461,656
在建工程2,367--03,041112,254523,346
无形资产14,621-6.94%15,71117,51415,37617,233
商誉0--0000
其他非流动资产670,84814.76%584,587556,768569,205563,729
1,501,9141.03%1,486,5781,539,5811,552,3711,565,965

流动资产
货币资金304,517-73.54%1,151,0451,001,3271,039,366651,463
应收账款1,293,2035.52%1,225,5171,298,8791,410,5191,287,074
存货130,097-7.61%140,807176,882173,536153,646
其他流动资产740,72712,614.16%5,82610,91333,47652,918
2,468,543-2.17%2,523,1952,488,0012,656,8972,145,100

流动负债
短期借款0-100.00%139,896186,889190,914109,296
应付票据790--09384,00017,804
应付帐款4,11639.43%2,9524,9663,12916,338
其他流动负债317,7767.19%296,472373,577483,682468,270
322,682-26.55%439,321566,369681,725611,708
流动资产净值2,145,8612.97%2,083,8751,921,6321,975,1731,533,392
资产总额减流动负债3,647,7742.17%3,570,4523,461,2133,527,5433,099,357

非流动负债
长期借款0--00015,748
应付债券0--0000
其他非流动负债34,1393.47%32,99313,70513,4927,941
34,1393.47%32,99313,70513,49223,689

总权益
    实收股本129,9470.00%129,947132,947134,650134,650
    储备项目3,483,6892.24%3,407,5133,314,5623,379,4012,941,018
股东权益3,613,6362.15%3,537,4603,447,5093,514,0523,075,668
非控股权益0--0000